trial
as of 2026-07-01Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
NCTId NCT01152697
at a glance
— · Completed
Enrollment 30 (actual)
Sponsored by University Hospitals Cleveland Medical Center
Primary completion 2012-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2010-06
Primary completion
2012-08
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
University Hospitals Cleveland Medical CenterLead Sponsor
Case Western Reserve UniversityCollaborator
Investigators
1
Martha Sajatovic, MDPrincipal Investigator
Sites
1 total
Cleveland, United States
Facts & assertions
4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2012-08
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person